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patients had LAM. Of the 31 patients who underwent LLD, 23 were treated as inpatients and 9 were treated as outpatients.
Study design
This was a single-centre, retrospective study. The median length of follow-up was 34 months. The number of patients lost to follow-up was not reported. LLD was not technically feasible in one patient because they were too obese. There was no blinding method for the assessment of outcomes.
Analysis of effectiveness
The analysis of the clinical study was based on treatment completers only. The study reported median rather than mean values. The groups were not comparable in terms of gender (12 men and 19 women in the LAM group and 22 men and 9 women in the LLD group, p<0.05) or age (the median age was 42 years in the LAM group and 37 years in the LLD group, p<0.05). Three LLD patients, but no LAM patients, had undergone previous laminectomies. There was no adjustment for any confounding factors.
The primary clinical outcome measure was time to rehabilitation measured in days.
Secondary clinical outcome measures were: estimated blood lost during the operation; time in the operating room; length of stay in the hospital; and percentage of pain free days on long-term follow-up.
Effectiveness results
LLD patients had significantly lower median rehabilitation time (23 days) compared with the LAM group (71 days, p<0.01).
LLD patients had significantly lower median estimated blood loss (10ml) compared with the LAM group (55ml, p<0.01).
LLD patients had significantly lower median operating room time (210 minutes) compared with the LAM group (158 minutes, p<0.01).
LLD patients had significantly lower median length of stay (2 days) compared with the LAM group (4 days, p<0.01).
On long-term follow-up, 58% of the LLD group remained pain free compared with 39% of the LAM group, (not significant).
Clinical conclusions
The authors concluded that LLD is a safe, minimally invasive operation for managing disabling L5-S1 lumbar disk herniation, and is superior to LAM in many respects.
Measure of benefits used in the economic analysis
No summary measure of benefits was used in the economic analysis.
Direct costs
Quantities and costs were not analysed separately. Hospital charges to the patients were measured but the type of costs included in the analysis was not reported explicitly. The time horizon for the study was not reported. It was not clear if the estimation of the quantities and costs was based on a guess or on actual data. The source of the quantity and cost data was not reported. The costs were collected for the period January 1992 to November 1994. The price year was not reported. Discounting was not carried out due to the short time of the study with respect to the valuation of costs (less than one year).
Validity of estimate of measure of benefit
This study reported effectiveness measures but did not include measures to combine the different clinical outcomes into one measure or to evaluate the value of the improvements in clinical status to patients.
Validity of estimate of costs
This study reported patient charge data rather than costs associated with the management of patients with herniated intervertebral disks from the hospital perspective. The study did not report any details about the time horizon or methods of collecting the patient charge data. It is therefore not possible to assess whether the results of this US based study are robust or applicable to the UK health care setting.
Mean costs are the most appropriate statistical summary measure of costs to inform decision-making but this study reports median costs.
Other issues
There was a lack of evidence that the results of the study were internally valid. This meant that the study does not provide clear evidence that the alternatives compared were equivalent in terms of outcome.
